Being the organ which comes in direct contact with the rest of the world – our skin plays a vital role in protecting our body from damage. Thus, it is imperative to take care good care of it. There are several skin conditions, which affect humans. Some may be mild like rashes, while some may be chronic. This Psoriasis Day, distinguished Doctors guide us about Psoriasis.
“Psoriasis is chronic disease of the immune system that causes the abnormal growth of skin cells. While a normal skin cell matures in 28 to 30 days and is shed from the skin’s surface unnoticed, a psoriatic skin cell takes only 3 to 4 days to mature and move to the surface, resulting in cells piling up and forming the scaly lesions,” says Dr Nagaraja from Bangalore.
It is estimated that, worldwide, nearly 125 million people are affected, where nearly 3% of the world’s population is suffering from psoriasis and more than 1/3rd of patients with Chronic Plaque Psoriasis (CPP) suffer from its moderate to severe form. According to Dr D. G Saple from Mumbai, “Psoriasis is a serious condition causing inflammation not only of skin but internal multisystem involvement with comorbidities, strongly affecting the way a person sees himself and the way he is seen by others causing negative effects on quality of life and other psychological issues like depression, suicidal ideation, anxiety and sexual dysfunction as well”.
Dr Bhumesh Kumar Katakam from Hyderabad shares “Psoriasis is not just a cosmetic problem as skin inflammation in psoriasis is just the tip of the iceberg – there is increasing evidence suggesting links with serious health concerns such as cardiovascular disease, diabetes, liver disease, depression and obesity”. It has been increasing due to the modern stressful lifestyle, lack of adequate physical activities, and associated risk of metabolic syndrome. Although not a life threatening disease, Psoriasis can be difficult to live with.
Psoriasis can be managed by using proper medications and maintaining a healthy lifestyle. We at Cadila Pharmaceuticals are working towards redefining the dermal treatment paradigm through biosimilars like Adalimumab. Quality, affordability with ease of usage stays our primary focus with the aim to make life easier, simpler and healthier for people of all walks of life.
Mr. Amit Ajmera, Vice President, Cadila Pharmaceuticals, opined that biologics have become a standard of care for treatment of psoriasis by helping millions to live with better Quality of Life (QoL). In India, the usage continues to be restricted especially due to prohibiting cost and need for injections as an in-patient hospital setting without insurance coverage. We at Cadila are precisely addressing that issue by offering a product which is quite affordable and can be given in regular OPD setting.
We need to continue to develop awareness programs around affordable biosimilars.
Disclaimer: All content contained in and available through this article are for general information and self-awareness purposes. This article has been created in good faith by Cadila Pharmaceuticals Ltd. No representation is made as to the completeness or accuracy of the information. All rights pertaining to this post are reserved with Cadila Pharmaceuticals Ltd.